CorMedix, Inc.

85
Strong Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US21900C3088
USD
7.02
0.23 (3.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
CorMedix, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
150.00
-19.00
-46.00
-30.00
-29.00
-27.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
7.00
-39.00
2.00
1.00
1.00
-2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
175.00
-50.00
-38.00
-24.00
-21.00
-21.00
Cash Flow from Investing Activities
-308.00
21.00
-17.00
-3.00
-9.00
7.00
Cash Flow from Financing Activities
238.00
26.00
55.00
17.00
41.00
40.00
Net Cash Inflow / Outflow
105.00
-3.00
0.00
-10.00
11.00
25.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CorMedix, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
150.016
-1.005
151.00
15026.97%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
7.268
-1.082
8.00
771.72%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
175.046
-4.359
179.00
4115.74%
Cash Flow from Investing Activities
-308.43
0.167
-308.00
-184788.62%
Cash Flow from Financing Activities
238.453
0
238.00
0.00%
Net Cash Inflow / Outflow
105.069
-4.192
109.00
2606.42%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 445.84% vs -31.78% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
175.05
-50.61
445.84%